Literature DB >> 1922100

Expression of CA III in rodent models of obesity.

L W Stanton1, P A Ponte, R T Coleman, M A Snyder.   

Abstract

To achieve a better understanding of the biochemical basis of obesity, we have undertaken comparative analyses of adipose tissue of lean and obese mice. By two-dimensional gel analysis, carbonic anhydrase-III (CA III) has been identified as a major constituent of murine adipose tissue. Quantitative comparisons of CA III protein and mRNA levels indicate that this enzyme is expressed at lower levels in adipose tissue from animals that were either genetically obese or had experimentally induced obesity compared to levels in the corresponding lean controls. This decrease in CA III expression was unique to adipose tissue, since other CA III-containing organs and tissues did not show a change when lean and obese animals were compared. Additionally, levels of CA III in adipose tissue from obese animals responded to acute changes in energy balance of the animal. These results are discussed in light of possible metabolic roles for CA III.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922100     DOI: 10.1210/mend-5-6-860

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  14 in total

1.  Loss of Uncoupling Protein 3 Attenuates Western Diet-Induced Obesity, Systemic Inflammation, and Insulin Resistance in Rats.

Authors:  Tyler M Lomax; Sadia Ashraf; Gizem Yilmaz; Romain Harmancey
Journal:  Obesity (Silver Spring)       Date:  2020-07-27       Impact factor: 5.002

2.  Molecular determinants of S-glutathionylation of carbonic anhydrase 3.

Authors:  Geumsoo Kim; Rodney L Levine
Journal:  Antioxid Redox Signal       Date:  2005 Jul-Aug       Impact factor: 8.401

3.  Carbonic anhydrase III regulates peroxisome proliferator-activated receptor-γ2.

Authors:  Maria C Mitterberger; Geumsoo Kim; Ursula Rostek; Rodney L Levine; Werner Zwerschke
Journal:  Exp Cell Res       Date:  2012-02-28       Impact factor: 3.905

4.  Fine mapping a major obesity locus (jObes1) using a Berlin Fat Mouse × B6N advanced intercross population.

Authors:  D Arends; S Heise; S Kärst; J Trost; G A Brockmann
Journal:  Int J Obes (Lond)       Date:  2016-08-19       Impact factor: 5.095

5.  Carbonic anhydrase III is not required in the mouse for normal growth, development, and life span.

Authors:  Geumsoo Kim; Tae-Hoon Lee; Petra Wetzel; Cornelia Geers; Mary Ann Robinson; Timothy G Myers; Jennie W Owens; Nancy B Wehr; Michael W Eckhaus; Gerolf Gros; Anthony Wynshaw-Boris; Rodney L Levine
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

6.  Management of dietary essential metals (iron, copper, zinc, chromium and manganese) by Wistar and Zucker obese rats fed a self-selected high-energy diet.

Authors:  J A Fernández-López; M Esteve; I Rafecas; X Remesar; M Alemany
Journal:  Biometals       Date:  1994-04       Impact factor: 2.949

Review 7.  Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors.

Authors:  Melissa A Pinard; Brian Mahon; Robert McKenna
Journal:  Biomed Res Int       Date:  2015-02-24       Impact factor: 3.411

8.  Proteomic Identification of Target Proteins of Thiodigalactoside in White Adipose Tissue from Diet-Induced Obese Rats.

Authors:  Hilal Ahmad Parray; Jong Won Yun
Journal:  Int J Mol Sci       Date:  2015-06-25       Impact factor: 5.923

9.  Carbonic anhydrases III and IV autoantibodies in rheumatoid arthritis, systemic lupus erythematosus, diabetes, hypertensive renal disease, and heart failure.

Authors:  Chengeng Liu; Yue Wei; Jianmin Wang; Langan Pi; Jianjun Huang; Peichang Wang
Journal:  Clin Dev Immunol       Date:  2012-09-16

10.  Isomer-specific effects of CLA on gene expression in human adipose tissue depending on PPARgamma2 P12A polymorphism: a double blind, randomized, controlled cross-over study.

Authors:  J Herrmann; D Rubin; R Häsler; U Helwig; M Pfeuffer; A Auinger; C Laue; P Winkler; S Schreiber; D Bell; J Schrezenmeir
Journal:  Lipids Health Dis       Date:  2009-08-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.